Cardio-oncology (London, England)

Keyphrases

Publications

volume 9, number 1, 2023

Leart Berdica, Erisa Kola, Daniela Nakuci, Edlira Horjeti, Mehdi Alimehmeti
Cardiac hemangioma presenting as a primary cardiac tumor. Cardio-oncology (London, England) 9 (1) (2023)
Christine Auberle, Daniel Lenihan, Feng Gao, Amanda Cashen
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardio-oncology (London, England) 9 (1) (2023)
Tomohiro Kaneko, Sakiko Miyazaki, Azusa Kurita, Ryoko Morimoto, Shun Tsuchiya, Naoki Watanabe, Tomoiku Takaku, Norio Komatsu, Tohru Minamino
Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study. Cardio-oncology (London, England) 9 (1) (2023)
Sherry-Ann Brown, Brian Y Chung, Krishna Doshi, Abdulaziz Hamid, Erin Pederson, Ragasnehith Maddula, Allen Hanna, Indrajit Choudhuri, Rodney Sparapani, Mehri Bagheri Mohamadi Pour, Jun Zhang, Anai N Kothari, Patrick Collier, Pedro Caraballo, Peter Noseworthy, Adelaide Arruda-Olson, null null
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardio-oncology (London, England) 9 (1) (2023)
Jesus Jimenez, Nicolas Kostelecky, Joshua D Mitchell, Kathleen W Zhang, Chieh-Yu Lin, Daniel J Lenihan, Kory J Lavine
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance. Cardio-oncology (London, England) 9 (1) (2023)
Jianfeng Ye, Luming Zhang, Jun Lyu, Yidan Wang, Shiqi Yuan, Zhifeng Qin, Yu Liu, Tao Huang, Jinwei Tian, Haiyan Yin
Malignant cancer may increase the risk of all-cause in-hospital mortality in patients with acute myocardial infarction: a multicenter retrospective study of two large public databases. Cardio-oncology (London, England) 9 (1) (2023)
Leart Berdica, Erisa Kola, Daniela Nakuci, Edlira Horjeti, Mehdi Alimehmeti
Cardiac hemangioma presenting as a primary cardiac tumor. Cardio-oncology (London, England) 9 (1) (2023)
Mônica M C Becker, Gustavo F A Arruda, Diego R F Berenguer, Roberto O Buril, Daniela Cardinale, Simone C S Brandão
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18 F-FDG PET/CT as a new biomarker. Cardio-oncology (London, England) 9 (1) (2023)
Khan O Mohammad, Hanna Fanous, Sneha Vakamudi, Yan Liu
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression. Cardio-oncology (London, England) 9 (1) (2023)
Jesus Jimenez, Nicolas Kostelecky, Joshua D Mitchell, Kathleen W Zhang, Chieh-Yu Lin, Daniel J Lenihan, Kory J Lavine
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance. Cardio-oncology (London, England) 9 (1) (2023)
Massimiliano Camilli, Juan Guido Chiabrando, Marco Lombardi, Marco Giuseppe Del Buono, Rocco Antonio Montone, Antonella Lombardo, Filippo Crea, Giorgio Minotti
Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis. Cardio-oncology (London, England) 9 (1) (2023)
Yitao Zhang, Zicheng Huang, Sutian Hu, Jinhong Si, Shiyao Cheng, Zhichong Chen, Jiaojie Xue, Xue Lou, Huajing Peng, Zequan Li, Mao Ouyang, Xiang Gao, Weijie Zeng
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgery. Cardio-oncology (London, England) 9 (1) (2023)
Massimiliano Camilli, Juan Guido Chiabrando, Marco Lombardi, Marco Giuseppe Del Buono, Rocco Antonio Montone, Antonella Lombardo, Filippo Crea, Giorgio Minotti
Cancer incidence and mortality in patients diagnosed with heart failure: results from an updated systematic review and meta-analysis. Cardio-oncology (London, England) 9 (1) (2023)
Ankur Sheel, Junu Bae, Ashlee Asada, Gregory A Otterson, Ragavendra R Baliga, Kristin L Koenig
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case report. Cardio-oncology (London, England) 9 (1) (2023)
Jianfeng Ye, Luming Zhang, Jun Lyu, Yidan Wang, Shiqi Yuan, Zhifeng Qin, Yu Liu, Tao Huang, Jinwei Tian, Haiyan Yin
Malignant cancer may increase the risk of all-cause in-hospital mortality in patients with acute myocardial infarction: a multicenter retrospective study of two large public databases. Cardio-oncology (London, England) 9 (1) (2023)
Meer R Zafar, Ashutosh Sharma, Sunitha Shyam Sunder, Badri Karthikeyan, Makoto Nagahama, Andrew Atia, Ronak Bahuva, Saraswati Pokharel, Vijay Iyer, Sharma Kattel, Umesh C Sharma
Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation. Cardio-oncology (London, England) 9 (1) (2023)
Sarju Ganatra, Sonu Abraham, Ashish Kumar, Rohan Parikh, Rushin Patel, Sumanth Khadke, Amudha Kumar, Victor Liu, Andrea Nathalie Rosas Diaz, Tomas G Neilan, David Martin, Bruce Hook, Sourbha S Dani, Aarti Asnani, Anju Nohria
Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer. Cardio-oncology (London, England) 9 (1) (2023)
Christine Auberle, Daniel Lenihan, Feng Gao, Amanda Cashen
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardio-oncology (London, England) 9 (1) (2023)
N Jacobi, S Ortman, L Buda, Daniel Duprez
Effect of insulin resistance on CAC scores in cancer survivors. Cardio-oncology (London, England) 9 (1) (2023)
Sherry-Ann Brown, Brian Y Chung, Krishna Doshi, Abdulaziz Hamid, Erin Pederson, Ragasnehith Maddula, Allen Hanna, Indrajit Choudhuri, Rodney Sparapani, Mehri Bagheri Mohamadi Pour, Jun Zhang, Anai N Kothari, Patrick Collier, Pedro Caraballo, Peter Noseworthy, Adelaide Arruda-Olson, null null
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardio-oncology (London, England) 9 (1) (2023)
Yan Liu
A novel cardio-oncology service line model in optimizing care access, quality and equity for large, multi-hospital health systems. Cardio-oncology (London, England) 9 (1) (2023)
Anthony F Yu, Chau T Dang, Justine Jorgensen, Chaya S Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy. Cardio-oncology (London, England) 9 (1) (2023)
Mônica M C Becker, Gustavo F A Arruda, Diego R F Berenguer, Roberto O Buril, Daniela Cardinale, Simone C S Brandão
Anthracycline cardiotoxicity: current methods of diagnosis and possible role of 18 F-FDG PET/CT as a new biomarker. Cardio-oncology (London, England) 9 (1) (2023)
Sherry-Ann Brown, Brian Y Chung, Krishna Doshi, Abdulaziz Hamid, Erin Pederson, Ragasnehith Maddula, Allen Hanna, Indrajit Choudhuri, Rodney Sparapani, Mehri Bagheri Mohamadi Pour, Jun Zhang, Anai N Kothari, Patrick Collier, Pedro Caraballo, Peter Noseworthy, Adelaide Arruda-Olson, null null
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardio-oncology (London, England) 9 (1) (2023)
Anthony F Yu, Chau T Dang, Justine Jorgensen, Chaya S Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy. Cardio-oncology (London, England) 9 (1) (2023)
Aswini Kumar, Aswanth Reddy, Arjun Sekar
Enzalutamide induced non-ischemic cardiomyopathy. A case report and review of literature on anti-androgen therapy-related cardiovascular events. Cardio-oncology (London, England) 9 (1) (2023)
Tomohiro Kaneko, Sakiko Miyazaki, Azusa Kurita, Ryoko Morimoto, Shun Tsuchiya, Naoki Watanabe, Tomoiku Takaku, Norio Komatsu, Tohru Minamino
Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study. Cardio-oncology (London, England) 9 (1) (2023)
Aswini Kumar, Aswanth Reddy, Arjun Sekar
Enzalutamide induced non-ischemic cardiomyopathy. A case report and review of literature on anti-androgen therapy-related cardiovascular events. Cardio-oncology (London, England) 9 (1) (2023)
Sherry-Ann Brown, Brian Y Chung, Krishna Doshi, Abdulaziz Hamid, Erin Pederson, Ragasnehith Maddula, Allen Hanna, Indrajit Choudhuri, Rodney Sparapani, Mehri Bagheri Mohamadi Pour, Jun Zhang, Anai N Kothari, Patrick Collier, Pedro Caraballo, Peter Noseworthy, Adelaide Arruda-Olson, null null
Patient similarity and other artificial intelligence machine learning algorithms in clinical decision aid for shared decision-making in the Prevention of Cardiovascular Toxicity (PACT): a feasibility trial design. Cardio-oncology (London, England) 9 (1) (2023)
Ali Mir, Yasra Badi, Seif Bugazia, Anas Zakarya Nourelden, Ahmed Hashem Fathallah, Khaled Mohamed Ragab, Mohammed Alsillak, Sarah Makram Elsayed, Abdulrahman Ibrahim Hagrass, Sawyer Bawek, Mohamad Kalot, Zachary L Brumberger
Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis. Cardio-oncology (London, England) 9 (1) (2023)
Sanjay Divakaran, Diana M Lopez, Sean M Parks, Jon Hainer, Andrea K Ng, Ron Blankstein, Marcelo F Di Carli, Anju Nohria
Functional testing, coronary artery calcifications, and outcomes in Hodgkin lymphoma survivors treated with chest radiation. Cardio-oncology (London, England) 9 (1) (2023)
Jianfeng Ye, Luming Zhang, Jun Lyu, Yidan Wang, Shiqi Yuan, Zhifeng Qin, Yu Liu, Tao Huang, Jinwei Tian, Haiyan Yin
Malignant cancer may increase the risk of all-cause in-hospital mortality in patients with acute myocardial infarction: a multicenter retrospective study of two large public databases. Cardio-oncology (London, England) 9 (1) (2023)
Sanjay Divakaran, Diana M Lopez, Sean M Parks, Jon Hainer, Andrea K Ng, Ron Blankstein, Marcelo F Di Carli, Anju Nohria
Functional testing, coronary artery calcifications, and outcomes in Hodgkin lymphoma survivors treated with chest radiation. Cardio-oncology (London, England) 9 (1) (2023)
Ali Mir, Yasra Badi, Seif Bugazia, Anas Zakarya Nourelden, Ahmed Hashem Fathallah, Khaled Mohamed Ragab, Mohammed Alsillak, Sarah Makram Elsayed, Abdulrahman Ibrahim Hagrass, Sawyer Bawek, Mohamad Kalot, Zachary L Brumberger
Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis. Cardio-oncology (London, England) 9 (1) (2023)
Meer R Zafar, Ashutosh Sharma, Sunitha Shyam Sunder, Badri Karthikeyan, Makoto Nagahama, Andrew Atia, Ronak Bahuva, Saraswati Pokharel, Vijay Iyer, Sharma Kattel, Umesh C Sharma
Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation. Cardio-oncology (London, England) 9 (1) (2023)
Leart Berdica, Erisa Kola, Daniela Nakuci, Edlira Horjeti, Mehdi Alimehmeti
Cardiac hemangioma presenting as a primary cardiac tumor. Cardio-oncology (London, England) 9 (1) (2023)
Dae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, Rahul Mhaskar, Kayla Reid, Sae Bom Lee, Salvatore Corallo, Melanie J Hidalgo-Vargas, Abhishek Kumar, Julio Chavez, Bijal Shah, Aleksandr Lazaryan, Farhad Khimani, Taiga Nishihori, Christina Bachmeier, Rawan Faramand, Michael G Fradley, Daniel Jeong, Guilherme H Oliveira, Frederick L Locke, Marco L Davila, Mohammed Alomar
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study. Cardio-oncology (London, England) 9 (1) (2023)
Wafaa S El-Sherbeny, Nesreen M Sabry, Shaimaa B El-Saied, Basma Elnagar
Detection of right ventricular dysfunction by three - dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy. Cardio-oncology (London, England) 9 (1) (2023)
Christine Auberle, Daniel Lenihan, Feng Gao, Amanda Cashen
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardio-oncology (London, England) 9 (1) (2023)
Christine Auberle, Daniel Lenihan, Feng Gao, Amanda Cashen
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival. Cardio-oncology (London, England) 9 (1) (2023)
Ankur Sheel, Junu Bae, Ashlee Asada, Gregory A Otterson, Ragavendra R Baliga, Kristin L Koenig
Reversible cardiomyopathy in a patient with chronic myelomonocytic leukemia treated with decitabine/cedazuridine: a case report. Cardio-oncology (London, England) 9 (1) (2023)
Holden Eaton, Kerstin Nina Timm
Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment? Cardio-oncology (London, England) 9 (1) (2023)
Khan O Mohammad, Hanna Fanous, Sneha Vakamudi, Yan Liu
Refractory right ventricular myocarditis induced by immune checkpoint inhibitor despite therapy cessation and immune suppression. Cardio-oncology (London, England) 9 (1) (2023)
Meer R Zafar, Ashutosh Sharma, Sunitha Shyam Sunder, Badri Karthikeyan, Makoto Nagahama, Andrew Atia, Ronak Bahuva, Saraswati Pokharel, Vijay Iyer, Sharma Kattel, Umesh C Sharma
Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation. Cardio-oncology (London, England) 9 (1) (2023)
Matthew Dean, Min Jung Kim, Sharon Dimauro, Susan Tannenbaum, Garth Graham, Bruce T Liang, Agnes S Kim
Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy - a prospective analysis. Cardio-oncology (London, England) 9 (1) (2023)
Holden Eaton, Kerstin Nina Timm
Mechanisms of trastuzumab induced cardiotoxicity - is exercise a potential treatment? Cardio-oncology (London, England) 9 (1) (2023)
Yan Liu
A novel cardio-oncology service line model in optimizing care access, quality and equity for large, multi-hospital health systems. Cardio-oncology (London, England) 9 (1) (2023)
Anthony F Yu, Chau T Dang, Justine Jorgensen, Chaya S Moskowitz, Patricia DeFusco, Eric Oligino, Kevin C Oeffinger, Jennifer E Liu, Richard M Steingart
Rationale and design of a cardiac safety study for reduced cardiotoxicity surveillance during HER2-targeted therapy. Cardio-oncology (London, England) 9 (1) (2023)
Yitao Zhang, Zicheng Huang, Sutian Hu, Jinhong Si, Shiyao Cheng, Zhichong Chen, Jiaojie Xue, Xue Lou, Huajing Peng, Zequan Li, Mao Ouyang, Xiang Gao, Weijie Zeng
The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgery. Cardio-oncology (London, England) 9 (1) (2023)
Ali Mir, Yasra Badi, Seif Bugazia, Anas Zakarya Nourelden, Ahmed Hashem Fathallah, Khaled Mohamed Ragab, Mohammed Alsillak, Sarah Makram Elsayed, Abdulrahman Ibrahim Hagrass, Sawyer Bawek, Mohamad Kalot, Zachary L Brumberger
Efficacy and safety of cardioprotective drugs in chemotherapy-induced cardiotoxicity: an updated systematic review & network meta-analysis. Cardio-oncology (London, England) 9 (1) (2023)